ConductScience.org, home

Paper28049044

Lymphocytes contribute to biliary injury and fibrosis in experimental xenobiotic-induced cholestasis.

Joshi N and 3 others. Toxicology, 2017. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Lymphocytes contribute to biliary injury and fibrosis in experimental xenobiotic-induced cholestasis. Papers, record 28049044. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28049044

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Lymphocytes contribute to biliary injury and fibrosis in experimental xenobiotic-induced cholestasis.
PubMed
Journal
Toxicology
PubMed
Year
2017
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.28
iCite
Revised in PubMed
2018-11-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Joshi NNikita
2Kopec AKAnna K
3Cline-Fedewa HHolly
4Luyendyk JPJames P

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bile DuctsMajor topic
CholestasisMajor topic
Liver CirrhosisMajor topic
LymphocytesMajor topic
XenobioticsMajor topic
Animals
Male
Mice
Mice, Inbred C57BL
Mice, Knockout

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 ES017537NIEHS NIH HHSUnited StatesR01ES017537PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125869391ACG Clinical Guideline: Primary Sclerosing Cholangitis.Am J Gastroenterol2015https://conductscience.org/library/papers/25869391PubMed
227060337Role of hemostatic factors in hepatic injury and disease: animal models de-liver.J Thromb Haemost2016https://conductscience.org/library/papers/27060337PubMed
327605088Dose-dependent effects of alpha-naphthylisothiocyanate disconnect biliary fibrosis from hepatocellular necrosis.J Biochem Mol Toxicol2017https://conductscience.org/library/papers/27605088PubMed
423810223Primary sclerosing cholangitis.Lancet2013https://conductscience.org/library/papers/23810223PubMed
521356363Fibrinogen deficiency increases liver injury and early growth response-1 (Egr-1) expression in a model of chronic xenobiotic-induced cholestasis.Am J Pathol2011https://conductscience.org/library/papers/21356363PubMed
621037076The coagulation system contributes to alphaVbeta6 integrin expression and liver fibrosis induced by cholestasis.Am J Pathol2010https://conductscience.org/library/papers/21037076PubMed
75866807The nature of alpha-naphthylisothiocyanate-induced cholestasis.Toxicol Appl Pharmacol1965https://conductscience.org/library/papers/5866807PubMed
822094456Early growth response factor-1 limits biliary fibrosis in a model of xenobiotic-induced cholestasis in mice.Toxicol Sci2012https://conductscience.org/library/papers/22094456PubMed
917200187Alphav beta6 integrin regulates renal fibrosis and inflammation in Alport mouse.Am J Pathol2007https://conductscience.org/library/papers/17200187PubMed
1015085484The pathology of cholestasis.Semin Liver Dis2004https://conductscience.org/library/papers/15085484PubMed
1110655247Progressive development of a Th1-type hepatic cytokine profile in rats with experimental cholangitis.Hepatology2000https://conductscience.org/library/papers/10655247PubMed
1217924447Role of alphavbeta6 integrin in acute biliary fibrosis.Hepatology2007https://conductscience.org/library/papers/17924447PubMed
131846424An antibody to neutrophils attenuates alpha-naphthylisothiocyanate-induced liver injury.J Pharmacol Exp Ther1991https://conductscience.org/library/papers/1846424PubMed
1418221819Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies.J Hepatol2008https://conductscience.org/library/papers/18221819PubMed
1516015684Comparison of murine cirrhosis models induced by hepatotoxin administration and common bile duct ligation.World J Gastroenterol2005https://conductscience.org/library/papers/16015684PubMed
1624633426The antifibrinolytic drug tranexamic acid reduces liver injury and fibrosis in a mouse model of chronic bile duct injury.J Pharmacol Exp Ther2014https://conductscience.org/library/papers/24633426PubMed
1710025398The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis.Cell1999https://conductscience.org/library/papers/10025398PubMed
1823855292Vascular biology of the biliary epithelium.J Gastroenterol Hepatol2013https://conductscience.org/library/papers/23855292PubMed
1919554543Primary biliary cirrhosis.Hepatology2009https://conductscience.org/library/papers/19554543PubMed
209780343Molecular pathogenesis of cholestasis.N Engl J Med1998https://conductscience.org/library/papers/9780343PubMed

See all 45 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
33918904Pathological Study of Facial Eczema (Pithomycotoxicosis) in Sheep.Animals (Basel)2021https://conductscience.org/library/papers/33918904PubMed
33792809Suppression of systemic inflammation and signs of acute and chronic cholangitis by multi-kinase inhibitor 1-(4-Cl-benzyl)-3-chloro-4-(CF3-phenylamino)-1H-pyrrole-2,5-dione.Mol Cell Biochem2021https://conductscience.org/library/papers/33792809PubMed
31579944Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis.J Pathol2020https://conductscience.org/library/papers/31579944PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALPL249PubTator's text mininghttps://conductscience.org/library/genes/249NCBI Gene
COL1A11277PubTator's text mininghttps://conductscience.org/library/genes/1277NCBI Gene
ITGB63694PubTator's text mininghttps://conductscience.org/library/genes/3694NCBI Gene
RAG15896PubTator's text mininghttps://conductscience.org/library/genes/5896NCBI Gene
TGFB27042PubTator's text mininghttps://conductscience.org/library/genes/7042NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28049044

GET https://conductscience.org/api/papers/v1/28049044/references?page=2